Immunovant Inc. Common Stock vs Life Time Group Holdings Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Life Time Group Holdings Inc. Common Stock trades at $40.29 (market cap $9.05B). The key difference: Life Time Group Holdings Inc. Common Stock is the larger of the two by market cap, and Life Time Group Holdings Inc. Common Stock is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Life Time Group Holdings Inc. Common Stock for 0 Days on average.
| IMVT | LTH | |
|---|---|---|
Market Cap | $6.62B | $9.05B |
Volume | 1,131,364 | 1,609,972 |
Sector | Health | Consumer Cyclical |
52-Week High | $44.96 | $45.73 |
52-Week Low | $17.03 | $24.59 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $13.10B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Life Time operates fitness and lifestyle centers that offer gyms, classes, sports facilities, and wellness services.
Read more on LTH →